Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2016 - GlobalData

Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2016

Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2016 - GlobalData
Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2016
Published Nov 01, 2016
87 pages — Published Nov 01, 2016
Price US$ 2,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GlobalData's Medical Devices sector report, Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2016' provides an overview of Peripheral Embolic Protection Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Embolic Protection Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Peripheral Embolic Protection Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

  
Source:
Document ID
GDME0240EPD
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents25
  1.1 List of Tables42
  1.2 List of Figures61
2 Introduction71
  2.1 Peripheral Embolic Protection Devices Overview71
3 Products under Development86
  3.1 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development81
  3.2 Peripheral Embolic Protection Devices - Pipeline Products by Segment91
  3.3 Peripheral Embolic Protection Devices - Pipeline Products by Territory101
  3.4 Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path111
  3.5 Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date121
  3.6 Peripheral Embolic Protection Devices - Ongoing Clinical Trials131
4 Peripheral Embolic Protection Devices - Pipeline Products under Development by Companies142
  4.1 Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development141
  4.2 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development151
5 Peripheral Embolic Protection Devices Companies and Product Overview1638
  5.1 Abbott Vascular Inc. Company Overview161
    5.1.1 Abbott Vascular Inc. Pipeline Products &Ongoing Clinical Trials Overview162
  5.2 Avantec Vascular Corporation Company Overview181
    5.2.1 Avantec Vascular Corporation Pipeline Products &Ongoing Clinical Trials Overview181
  5.3 Cardio-Flow Ltd. Company Overview191
    5.3.1 Cardio-Flow Ltd. Pipeline Products &Ongoing Clinical Trials Overview191
  5.4 CardioGard Ltd. Company Overview201
    5.4.1 CardioGard Ltd. Pipeline Products &Ongoing Clinical Trials Overview203
  5.5 Claret Medical, Inc. Company Overview231
    5.5.1 Claret Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview233
  5.6 EKOS Corporation Company Overview261
    5.6.1 EKOS Corporation Pipeline Products &Ongoing Clinical Trials Overview266
  5.7 EMBA Medical Limited Company Overview321
    5.7.1 EMBA Medical Limited Pipeline Products &Ongoing Clinical Trials Overview323
  5.8 Inari Medical, Inc. Company Overview351
    5.8.1 Inari Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview353
  5.9 Innovative Cardiovascular Solutions, LLC Company Overview381
    5.9.1 Innovative Cardiovascular Solutions, LLC Pipeline Products &Ongoing Clinical Trials Overview382
  5.10 Innovia LLC Company Overview401
    5.10.1 Innovia LLC Pipeline Products &Ongoing Clinical Trials Overview401
  5.11 Keystone Heart Ltd. Company Overview411
    5.11.1 Keystone Heart Ltd. Pipeline Products &Ongoing Clinical Trials Overview414
  5.12 Medtronic plc Company Overview451
    5.12.1 Medtronic plc Pipeline Products &Ongoing Clinical Trials Overview452
  5.13 Metactive Medical, LLC Company Overview471
    5.13.1 Metactive Medical, LLC Pipeline Products &Ongoing Clinical Trials Overview471
  5.14 MIV Therapeutics Inc Company Overview481
    5.14.1 MIV Therapeutics Inc Pipeline Products &Ongoing Clinical Trials Overview481
  5.15 Neurosonix Ltd. Company Overview491
    5.15.1 Neurosonix Ltd. Pipeline Products &Ongoing Clinical Trials Overview491
  5.16 Trinity College Dublin Company Overview501
    5.16.1 Trinity College Dublin Pipeline Products &Ongoing Clinical Trials Overview501
  5.17 University of Minnesota Company Overview511
    5.17.1 University of Minnesota Pipeline Products &Ongoing Clinical Trials Overview511
  5.18 University of Toledo Company Overview521
    5.18.1 University of Toledo Pipeline Products &Ongoing Clinical Trials Overview522
6 Peripheral Embolic Protection Devices- Recent Developments5430
  6.1 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer541
  6.2 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results541
  6.3 Oct 03, 2016: American Journal of Cardiology Reports Data Showing New Brain Lesions in 94% of Patients Following TAVR551
  6.4 Sep 20, 2016: Claret Medical Submits Marketing Application to FDA for US Clearance of First Cerebral Protection System for Transcatheter Aortic Valve Replacement (TAVR)561
  6.5 Sep 19, 2016: TriGuard Cerebral Protection Device Demonstrates Safety and Significant Improvements in Brain Protection in Patients Undergoing TAVR Procedures571
  6.6 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services581
  6.7 Sep 14, 2016: Claret Medical Announces SENTINEL Pivotal IDE Trial to Be Featured in Late-Breaking Trial Session at Transcatheter Cardiovascular Therapeutics (TCT) Conference591
  6.8 Aug 30, 2016: MPSC Announces 2016 Interim Results601
  6.9 Aug 25, 2016: Medtronic Reports First Quarter Financial Results613
  6.10 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results641
  6.11 Aug 01, 2016: AngioDynamics to Raise Funds through Public Offering of Shares641
  6.12 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016651
  6.13 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results662
  6.14 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer681
  6.15 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors681
  6.16 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results691
  6.17 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic701
  6.18 Jun 15, 2016: Keystone Heart Announces First Patient Enrolled in New Study to Protect the Brain During TAVR701
  6.19 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation711
  6.20 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day721
  6.21 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results723
  6.22 May 31, 2016: Keystone Heart Appoints New President and Chief Executive Officer751
  6.23 May 19, 2016: TriGuard Cerebral Protection Device Shows Reduction in Stroke Rate and Improvement in Patients Neurological Outcomes in TAVR Procedures751
  6.24 May 09, 2016: Penumbra Reports First Quarter 2016 Financial Results761
  6.25 Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results762
  6.26 Mar 31, 2016: Penumbra to Present Final Results of Multicenter Prism Trial on Indigo System at SIR 2016781
  6.27 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device781
  6.28 Mar 08, 2016: Inari Medical Announces IDE Approval To Study The Flowtriever System For The Treatment Of Pulmonary Embolism781
  6.29 Feb 02, 2016: EndoShape Raises USD7 Million in Venture Financing791
  6.30 Jan 06, 2016: Penumbra Introduces POD Packing Coil for the Embolization of Peripheral Vessels and Aneurysms791
  6.31 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved801
  6.32 Dec 23, 2015: MicroPort Completed the First Distant Interactive Surgery in the Field of Coronary Interventional Treatment801
  6.33 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International Conference811
  6.34 Nov 23, 2015: Inari Medical And Inceptus Medical Announce Receipt Of TCT Innovation Award821
  6.35 Nov 18, 2015: EMBA Medical Cleared to Market Hourglass Peripheral Embolization Plug in New Zealand822
7 Appendix844
  7.1 Methodology842
  7.2 About GlobalData861
  7.3 Contact Us861
  7.4 Disclaimer871

Table Of Contents

GlobalData—GlobalData uses proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.

About the Author


Cite this Report

  
MLA:
GlobalData. "Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2016" Nov 01, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData/Peripheral-Embolic-Protection-Devices-Medical-Devices-Pipeline-Assessment-2016-2085-23842>
  
APA:
GlobalData. (2016). Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2016 Nov 01, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData/Peripheral-Embolic-Protection-Devices-Medical-Devices-Pipeline-Assessment-2016-2085-23842>
  
US$ 2,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.